JP2023506227A5 - - Google Patents
Info
- Publication number
- JP2023506227A5 JP2023506227A5 JP2022535965A JP2022535965A JP2023506227A5 JP 2023506227 A5 JP2023506227 A5 JP 2023506227A5 JP 2022535965 A JP2022535965 A JP 2022535965A JP 2022535965 A JP2022535965 A JP 2022535965A JP 2023506227 A5 JP2023506227 A5 JP 2023506227A5
- Authority
- JP
- Japan
- Prior art keywords
- hours
- minutes
- days
- ptpn2
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962947483P | 2019-12-12 | 2019-12-12 | |
| US62/947,483 | 2019-12-12 | ||
| PCT/US2020/064709 WO2021119554A1 (en) | 2019-12-12 | 2020-12-11 | Compositions and methods for potentiating immune activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023506227A JP2023506227A (ja) | 2023-02-15 |
| JP2023506227A5 true JP2023506227A5 (cg-RX-API-DMAC7.html) | 2023-12-18 |
Family
ID=76329104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535965A Pending JP2023506227A (ja) | 2019-12-12 | 2020-12-11 | 免疫活性を強化するための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12551555B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4073242A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023506227A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115103907A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020401376A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3163012A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021119554A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4073242A4 (en) | 2019-12-12 | 2024-01-03 | Kumquat Biosciences Inc. | Compositions and methods for potentiating immune activity |
| CN114668743B (zh) * | 2021-08-04 | 2025-08-08 | 贵州医科大学附属医院 | 抑制黑色素瘤生长的纳米载药系统的制备方法及应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100868587B1 (ko) | 2002-04-03 | 2008-11-12 | 노파르티스 아게 | Ｐｔｐａｓｅ 1ｂ 억제제로서의 5-치환된1,1-디옥소-1,2,5-티아졸리딘-3-온 유도체 |
| GB0225986D0 (en) | 2002-11-07 | 2002-12-11 | Astrazeneca Ab | Chemical compounds |
| UA94724C2 (en) | 2005-12-08 | 2011-06-10 | Новартис Аг | Thiadiazolidinone derivatives as antidiabetic agents |
| CA2630448A1 (en) | 2005-12-08 | 2007-06-14 | Novartis Ag | 1,1,3-trioxo-1,2,5-thiadiazolidines and their use as ptp-ases inhibitors |
| UA94921C2 (en) | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| CA2647472A1 (en) | 2006-03-31 | 2007-10-11 | Novartis Ag | Organic compounds |
| AR066820A1 (es) | 2007-06-04 | 2009-09-16 | Novartis Ag | Compuestos de tiadiazolidin-3 ona |
| WO2009049098A2 (en) | 2007-10-09 | 2009-04-16 | Indiana University Research & Technology Corporation | Materials and methods for regulating the activity of phosphatases |
| US9217012B2 (en) * | 2009-04-08 | 2015-12-22 | Indiana University Research And Technology Corporation | Inhibitors of protein tyrosine phosphatases |
| US9493436B2 (en) | 2011-04-26 | 2016-11-15 | Indiana University Research And Technology Corporation | Tyrosine phosphatase inhibitors and uses thereof to modulate the activity of enzymes involved in the pathology of Mycobacterium tuberculosis |
| WO2015127548A1 (en) * | 2014-02-28 | 2015-09-03 | The Royal Institution For The Advancement Of Learning / Mcgill University | Tc-ptp inhibitors as apc activators for immunotherapy |
| EP3154555A4 (en) * | 2014-06-10 | 2018-02-28 | Monash University | Method of producing leukocytes using ptpn2 inhibition for adoptive cell transfer |
| MA54884A (fr) * | 2015-07-01 | 2022-01-12 | Immatics Biotechnologies Gmbh | Neuartige peptide und kombination aus peptiden zur verwendung in der immuntherapie gegen ovarialkarzinom und andere karzinome |
| US20180325925A1 (en) * | 2015-11-06 | 2018-11-15 | Kyungpook National University Industry-Academic Cooperation Foundation | Composition for prevention or treatment of neuroinflammatory disease, containing protein tyrosine phosphatase inhibitor |
| WO2017205765A1 (en) | 2016-05-27 | 2017-11-30 | Yale University | Compositions and methods for inhibiting ptpn22 |
| WO2018227248A1 (en) * | 2017-06-13 | 2018-12-20 | Monash University | Methods and compositions for the treatment of obesity |
| WO2019036815A1 (en) | 2017-08-24 | 2019-02-28 | The Royal Institution For The Advancement Of Learning/Mcgill University | ENHANCEMENT OF CD8 + T LYMPHOCYTES FOR ADOPTIVE CELL THERAPY BY INHIBITING PTPN1 (PTP1B) AND PTPN2 (TC-PTP)) |
| CN112041433A (zh) | 2018-03-15 | 2020-12-04 | Ksq治疗公司 | 用于改进的免疫疗法的基因调控组合物和方法 |
| BR112020026086A2 (pt) | 2018-06-21 | 2021-03-23 | Calico Life Sciences Llc | inibidores da proteína tirosina fosfatase e métodos de uso destes |
| US20220081691A1 (en) * | 2018-08-07 | 2022-03-17 | Dana-Farber Cancer Institute, Inc | Modulating ptpn2 to increase immune responses and perturbing gene expression in hematopoietic stem cell lineages |
| IL286373B2 (en) | 2019-03-14 | 2026-03-01 | Calico Life Sciences Llc | Protein tyrosine phosphate inhibitor compounds and uses thereof |
| CN115003315A (zh) | 2019-12-04 | 2022-09-02 | 莫纳什大学 | 使用ptp1b和ptpn2抑制剂激活细胞毒性白细胞的方法 |
| EP4073242A4 (en) | 2019-12-12 | 2024-01-03 | Kumquat Biosciences Inc. | Compositions and methods for potentiating immune activity |
| CA3162069A1 (en) | 2019-12-18 | 2021-06-24 | Elliot P. Farney | Protein tyrosine phosphatase inhibitors and methods of use thereof |
| EP4077319A1 (en) | 2019-12-20 | 2022-10-26 | Calico Life Sciences LLC | Protein tyrosine phosphatase degraders and methods of use thereof |
| CN113827727B (zh) | 2020-06-24 | 2025-04-29 | 上海交通大学医学院附属瑞金医院 | Ptpn2抑制剂在kras突变肿瘤中的应用 |
| MX2023002953A (es) | 2020-09-11 | 2023-06-01 | Calico Life Sciences Llc | Inhibidores de proteína tirosina fosfatasa y métodos para su uso. |
-
2020
- 2020-12-11 EP EP20898012.8A patent/EP4073242A4/en active Pending
- 2020-12-11 WO PCT/US2020/064709 patent/WO2021119554A1/en not_active Ceased
- 2020-12-11 CN CN202080096581.7A patent/CN115103907A/zh active Pending
- 2020-12-11 AU AU2020401376A patent/AU2020401376A1/en active Pending
- 2020-12-11 JP JP2022535965A patent/JP2023506227A/ja active Pending
- 2020-12-11 CA CA3163012A patent/CA3163012A1/en active Pending
-
2022
- 2022-06-10 US US17/838,064 patent/US12551555B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113286879B (zh) | 用于细胞疗法之多样化抗原结合域、新颖平台及其他增强子 | |
| JP7487112B2 (ja) | Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用 | |
| JP2024520676A5 (cg-RX-API-DMAC7.html) | ||
| JP6420776B2 (ja) | 免疫療法のためのエンゲージャー細胞 | |
| JP2021525509A5 (cg-RX-API-DMAC7.html) | ||
| IL273201B1 (en) | Novel platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy | |
| ES2988584T3 (es) | Subconjunto de células NKT para persistencia y actividad terapéutica in vivo y propagación del mismo | |
| JP2019534246A5 (cg-RX-API-DMAC7.html) | ||
| JP7662588B2 (ja) | 遺伝子操作された薬物耐性ｔ細胞およびその使用方法 | |
| CN110352068A (zh) | 合成的免疫受体及其使用方法 | |
| EP3612222A1 (en) | Compositions and methods for treating cancer | |
| JP2019532997A5 (cg-RX-API-DMAC7.html) | ||
| JP2024509095A5 (cg-RX-API-DMAC7.html) | ||
| JP2020511462A5 (cg-RX-API-DMAC7.html) | ||
| WO2022199125A1 (zh) | 一种自分泌IL-15与anti-PD1融合蛋白的免疫细胞 | |
| JP2023506227A5 (cg-RX-API-DMAC7.html) | ||
| US12178786B2 (en) | Combination of cellular immunotherapy | |
| JP2024531446A5 (cg-RX-API-DMAC7.html) | ||
| JP7541390B2 (ja) | 免疫チェックポイント分子と結合可能な分子が融合したタンパク質およびその用途 | |
| CN112638428A (zh) | 嵌合抗原受体肿瘤浸润淋巴细胞 | |
| JP2018526453A5 (cg-RX-API-DMAC7.html) | ||
| JP2025513607A (ja) | Ｃｄ７遺伝子がノックアウトされた操作された免疫細胞及びその用途 | |
| GB2623191A (en) | Engineered chimeric fusion protein compositions and methods of use thereof | |
| WO2020142780A1 (en) | Car t cell methods and constructs | |
| CN111867598A (zh) | 肿瘤免疫赋活剂 |